Skip to content

Septerna, Inc. SEPN Change in Other Liabilities

Change in Other Liabilities at other companies

Amgen logo
AmgenAMGN
-$75M+3.8%
Precigen logo
PrecigenPGEN
-$28K
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$21M+6,207%
Alkermes logo
AlkermesALKS
$4.89M+71.5%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s change in other liabilities?
Septerna, Inc. (SEPN) reported change in other liabilities of $100K in Q1 2026.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.